CRISTOPH - a cluster-randomised intervention study to optimise the treatment of patients with hypertension in General Practice.
Standard
CRISTOPH - a cluster-randomised intervention study to optimise the treatment of patients with hypertension in General Practice. / Mortsiefer, Achim; Meysen, Tobias; Schumacher, Martin; Lintges, Claudia; Stamer, Maren; Schmacke, Norbert; Wegscheider, Karl; Abholz, Heinz-Harald; Jürgen, In der Schmitten.
in: BMC FAM PRACT, Jahrgang 9, 2008, S. 33.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - CRISTOPH - a cluster-randomised intervention study to optimise the treatment of patients with hypertension in General Practice.
AU - Mortsiefer, Achim
AU - Meysen, Tobias
AU - Schumacher, Martin
AU - Lintges, Claudia
AU - Stamer, Maren
AU - Schmacke, Norbert
AU - Wegscheider, Karl
AU - Abholz, Heinz-Harald
AU - Jürgen, In der Schmitten
PY - 2008
Y1 - 2008
N2 - BACKGROUND: Recent guidelines for the management of hypertension focus on treating patients according to their global cardiovascular risk (CVR), rather than strictly keeping blood pressure, or other risk factors, below set limit values. The objective of this study is to compare the effect of a simple versus a complex educational intervention implementing this new concept among General Practitioners (GPs). METHODS/DESIGN: A prospective longitudinal cluster-randomised intervention trial with 94 German GPs consecutively enroling 40 patients each with known hypertension. All GPs then received a written manual specifically developed to transfer the global concept of CVR into daily General Practice. After cluster-randomisation, half of the GPs additionally received a clinical outreach visit, with a trained peer discussing with them the concept of global CVR referring to example study patients from the respective GP. Main outcome measure is the improvement of calculated CVR six months after intervention in the subgroup of patients with high CVR (but no history of cardiovascular disease), defined as 10-year-mortality > or = 5% employing the European SCORE formula. Secondary outcome measures include the intervention's effect on single risk factors, and on prescription rates of drugs targeting CVR. All outcome measures are separately studied in the three subgroups of patients with 1. high CVR (defined as above), 2. low CVR (SCORE <5%), and 3. a history of cardiovascular disease. The influence of age, sex, social status, and the perceived quality of the respective doctor-patient-relation on the effects will be examined. DISCUSSION: To our knowledge, no other published intervention study has yet evaluated the impact of educating GPs with the goal to treat patients with hypertension according to their global cardiovascular risk. TRIAL REGISTRATION: ISRCTN44478543.
AB - BACKGROUND: Recent guidelines for the management of hypertension focus on treating patients according to their global cardiovascular risk (CVR), rather than strictly keeping blood pressure, or other risk factors, below set limit values. The objective of this study is to compare the effect of a simple versus a complex educational intervention implementing this new concept among General Practitioners (GPs). METHODS/DESIGN: A prospective longitudinal cluster-randomised intervention trial with 94 German GPs consecutively enroling 40 patients each with known hypertension. All GPs then received a written manual specifically developed to transfer the global concept of CVR into daily General Practice. After cluster-randomisation, half of the GPs additionally received a clinical outreach visit, with a trained peer discussing with them the concept of global CVR referring to example study patients from the respective GP. Main outcome measure is the improvement of calculated CVR six months after intervention in the subgroup of patients with high CVR (but no history of cardiovascular disease), defined as 10-year-mortality > or = 5% employing the European SCORE formula. Secondary outcome measures include the intervention's effect on single risk factors, and on prescription rates of drugs targeting CVR. All outcome measures are separately studied in the three subgroups of patients with 1. high CVR (defined as above), 2. low CVR (SCORE <5%), and 3. a history of cardiovascular disease. The influence of age, sex, social status, and the perceived quality of the respective doctor-patient-relation on the effects will be examined. DISCUSSION: To our knowledge, no other published intervention study has yet evaluated the impact of educating GPs with the goal to treat patients with hypertension according to their global cardiovascular risk. TRIAL REGISTRATION: ISRCTN44478543.
U2 - 10.1186/1471-2296-9-33
DO - 10.1186/1471-2296-9-33
M3 - SCORING: Zeitschriftenaufsatz
VL - 9
SP - 33
JO - BMC PRIM CARE
JF - BMC PRIM CARE
SN - 1471-2296
ER -
